
Harry Y. Oh
Examiner (ID: 6855, Phone: (571)270-5912 , Office: P/3664 )
| Most Active Art Unit | 3664 |
| Art Unit(s) | 4128, 3666, 3657, 3664 |
| Total Applications | 785 |
| Issued Applications | 654 |
| Pending Applications | 54 |
| Abandoned Applications | 99 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19512348
[patent_doc_number] => 20240344034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => Renal Progenitor Cells
[patent_app_type] => utility
[patent_app_number] => 18/757662
[patent_app_country] => US
[patent_app_date] => 2024-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18757662
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/757662 | Renal Progenitor Cells | Jun 27, 2024 | Pending |
Array
(
[id] => 19709514
[patent_doc_number] => 20250019656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => COMPOSITIONS AND METHODS FOR HEMATOPOIETIC STEM CELL TRANSPLANTS
[patent_app_type] => utility
[patent_app_number] => 18/744550
[patent_app_country] => US
[patent_app_date] => 2024-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18744550
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/744550 | COMPOSITIONS AND METHODS FOR HEMATOPOIETIC STEM CELL TRANSPLANTS | Jun 13, 2024 | Pending |
Array
(
[id] => 19543381
[patent_doc_number] => 20240360417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => CELL THERAPEUTIC AGENT FOR CANCER TREATMENT AND COMBINATION THERAPY WITH SAME
[patent_app_type] => utility
[patent_app_number] => 18/631774
[patent_app_country] => US
[patent_app_date] => 2024-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18631774
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/631774 | CELL THERAPEUTIC AGENT FOR CANCER TREATMENT AND COMBINATION THERAPY WITH SAME | Apr 9, 2024 | Pending |
Array
(
[id] => 18469168
[patent_doc_number] => 20230203452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => METHOD OF PRODUCING CONDITIONED MEDIUM FOR CULTURING PATIENT-DERIVED CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 18/171832
[patent_app_country] => US
[patent_app_date] => 2023-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18171832
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/171832 | METHOD OF PRODUCING CONDITIONED MEDIUM FOR CULTURING PATIENT-DERIVED CANCER CELLS | Feb 20, 2023 | Pending |
Array
(
[id] => 19800797
[patent_doc_number] => 20250066722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => METHODS FOR PRODUCTION OF FUNCTIONAL NEURONS
[patent_app_type] => utility
[patent_app_number] => 18/703641
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18703641
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/703641 | METHODS FOR PRODUCTION OF FUNCTIONAL NEURONS | Nov 9, 2022 | Pending |
Array
(
[id] => 18583134
[patent_doc_number] => 20230265393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => COMPOSITION AND METHODS FOR PRODUCING ADULT LIVER ORGANOIDS
[patent_app_type] => utility
[patent_app_number] => 17/935135
[patent_app_country] => US
[patent_app_date] => 2022-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/935135 | COMPOSITION AND METHODS FOR PRODUCING ADULT LIVER ORGANOIDS | Sep 25, 2022 | Pending |
Array
(
[id] => 18166269
[patent_doc_number] => 20230032871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => Recombinant Viral Particle for Gene and/or Cellular Therapy
[patent_app_type] => utility
[patent_app_number] => 17/812521
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812521 | Recombinant Viral Particle for Gene and/or Cellular Therapy | Jul 13, 2022 | Abandoned |
Array
(
[id] => 17982847
[patent_doc_number] => 20220348883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => HIGH-DENSITY CELL CULTURE METHOD
[patent_app_type] => utility
[patent_app_number] => 17/863785
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863785
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/863785 | HIGH-DENSITY CELL CULTURE METHOD | Jul 12, 2022 | Pending |
Array
(
[id] => 18140342
[patent_doc_number] => 20230014181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => CULTURE SYSTEM AND METHODS FOR IMPROVED MODELING OF NEUROLOGICAL CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/842715
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842715 | CULTURE SYSTEM AND METHODS FOR IMPROVED MODELING OF NEUROLOGICAL CONDITIONS | Jun 15, 2022 | Pending |
Array
(
[id] => 18077728
[patent_doc_number] => 20220403340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => MEDIA FOR CRYOPRESERVED CELLS AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/839138
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839138 | MEDIA FOR CRYOPRESERVED CELLS AND METHODS OF MAKING AND USING SAME | Jun 12, 2022 | Pending |
Array
(
[id] => 18751576
[patent_doc_number] => 20230354789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => INDIRECT SELECTIVE BREEDING METHOD OF HIGH-COLLAGEN MEAT GEESE
[patent_app_type] => utility
[patent_app_number] => 17/924687
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924687
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/924687 | INDIRECT SELECTIVE BREEDING METHOD OF HIGH-COLLAGEN MEAT GEESE | May 25, 2022 | Pending |
Array
(
[id] => 18160467
[patent_doc_number] => 20230027059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN NEURAL PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 17/748323
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748323
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748323 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN NEURAL PROGENITOR CELLS | May 18, 2022 | Pending |
Array
(
[id] => 18628487
[patent_doc_number] => 20230287352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHOD FOR NON-ENZYMATIC 3D CULTURE AND AMPLIFICATION OF MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/739127
[patent_app_country] => US
[patent_app_date] => 2022-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/739127 | Method for non-enzymatic 3D culture and amplification of mesenchymal stem cells | May 7, 2022 | Issued |
Array
(
[id] => 18285863
[patent_doc_number] => 20230101335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => EX VIVO TISSUE EXPLANT AND GRAFT PLATFORM AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/738843
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/738843 | EX VIVO TISSUE EXPLANT AND GRAFT PLATFORM AND USES THEREOF | May 5, 2022 | Pending |
Array
(
[id] => 17657370
[patent_doc_number] => 20220177835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHODS OF GENERATING AND ISOLATING MIDBRAIN DOPAMINE NEURONS
[patent_app_type] => utility
[patent_app_number] => 17/681113
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681113 | METHODS OF GENERATING AND ISOLATING MIDBRAIN DOPAMINE NEURONS | Feb 24, 2022 | Pending |
Array
(
[id] => 17774996
[patent_doc_number] => 20220241345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => INDUCED PLURIPOTENT STEM CELL DERIVED GLIAL ENRICHED PROGENITOR CELLS FOR THE TREATMENT OF WHITE MATTER STROKE
[patent_app_type] => utility
[patent_app_number] => 17/674708
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674708
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674708 | INDUCED PLURIPOTENT STEM CELL DERIVED GLIAL ENRICHED PROGENITOR CELLS FOR THE TREATMENT OF WHITE MATTER STROKE | Feb 16, 2022 | Pending |
Array
(
[id] => 18064450
[patent_doc_number] => 20220395537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => METHODS OF STEM CELL CULTURE FOR OBTAINING PRODUCTS, AND IMPLEMENTATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/578442
[patent_app_country] => US
[patent_app_date] => 2022-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578442 | METHODS OF STEM CELL CULTURE FOR OBTAINING PRODUCTS, AND IMPLEMENTATIONS THEREOF | Jan 17, 2022 | Abandoned |
Array
(
[id] => 18483606
[patent_doc_number] => 20230210906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => Composite 3D Brain Organoids with Optic Structures, Uses Thereof and Culture Medium for Obtaining Them
[patent_app_type] => utility
[patent_app_number] => 17/570266
[patent_app_country] => US
[patent_app_date] => 2022-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/570266 | Composite 3D Brain Organoids with Optic Structures, Uses Thereof and Culture Medium for Obtaining Them | Jan 5, 2022 | Pending |
Array
(
[id] => 17792411
[patent_doc_number] => 20220251502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => METHODS FOR REDUCING THE OXIDATION LEVEL OF CYSTEINE RESIDUES IN A SECRETED RECOMBINANTLY-EXPRESSED PROTEIN DURING CELL CULTURE
[patent_app_type] => utility
[patent_app_number] => 17/557921
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557921
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/557921 | METHODS FOR REDUCING THE OXIDATION LEVEL OF CYSTEINE RESIDUES IN A SECRETED RECOMBINANTLY-EXPRESSED PROTEIN DURING CELL CULTURE | Dec 20, 2021 | Pending |
Array
(
[id] => 18420481
[patent_doc_number] => 20230174943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => CELLULAR COMPOSITION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/543491
[patent_app_country] => US
[patent_app_date] => 2021-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17543491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/543491 | CELLULAR COMPOSITION AND USES THEREOF | Dec 5, 2021 | Pending |